Unternehmen Bristol-Myers Squibb Company BOERSE MUENCHEN
Aktien
850501
US1101221083
BRM
Pharmazeutika
Realtime
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
38,12 EUR | +0,29 % |
|
-5,00 % | -18,26 % |
Kurzporträt
Die Vereinigten Staaten machen 70,1% des Nettoumsatzes aus.
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 46 159 | 100,0 % | 45 006 | 100,0 % | -2,50 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
70,1
%
| 31 828 | 69,0 % | 31 555 | 70,1 % | -0,86 % |
International
28,3
%
| 13 497 | 29,2 % | 12 752 | 28,3 % | -5,52 % |
Other
1,6
%
| 834 | 1,8 % | 699 | 1,6 % | -16,19 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 53 | 01.02.15 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 20.11.19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 01.01.03 | |
Chief Tech/Sci/R&D Officer | - | - | |
Samit Hirawat
CTO | Chief Tech/Sci/R&D Officer | 55 | 01.01.19 |
Robert Plenge
CTO | Chief Tech/Sci/R&D Officer | 53 | 01.11.19 |
Laura Hortas
IRO | Public Communications Contact | - | - |
Corporate Officer/Principal | - | - | |
Cari Gallman
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20.11.19 |
Peter Arduini
BRD | Director/Board Member | 59 | 01.04.16 |
Derica Rice
BRD | Director/Board Member | 59 | 01.09.20 |
Paula Price
BRD | Director/Board Member | 62 | 01.09.20 |
Theodore Samuels
BRD | Director/Board Member | 69 | 21.02.17 |
David Elkins
DFI | Director of Finance/CFO | 55 | 20.11.19 |
Chief Executive Officer | 53 | 01.02.15 | |
Julia Haller
BRD | Director/Board Member | 69 | 20.11.19 |
Deepak Bhatt
BRD | Director/Board Member | 56 | 14.06.22 |
Karen Vousden
BRD | Director/Board Member | 66 | 01.01.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 2 923 100 096 | 2 024 918 592 ( 69,27 %) | 896 000 000 ( 30,65 %) | 69,27 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
5 075 304 | 5,31% | 136 322 665 $ | |
759 145 | 6,36% | 19 358 198 $ | |
COMPUGEN LTD. 5,31% | 4 757 058 | 5,31% | 10 322 816 $ |
CELULARITY INC. 5,49% | 1 195 327 | 5,49% | 3 717 467 $ |
Unternehmenskontakt
Bristol Myers Squibb Co.
Route 206 & Province Line Road
08543, Princeton
+609 252 4621
http://www.bms.com![Straße Bristol-Myers Squibb Company(BRM)](https://cdn.zonebourse.com/static/address/111960778.png)
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Bristol-Myers Squibb India Pvt Ltd.
![]() Bristol-Myers Squibb India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb India Pvt Ltd. is an Indian company that discovers, develops, and delivers medicines for immuno-oncology. The company is based in Mumbai, India. |
Pharmaceuticals: Major
|
Bristol-Myers Squibb de México S de RL de CV
![]() Bristol-Myers Squibb de México S de RL de CV Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The company is located in Mexico. |
Pharmaceuticals: Major
|
Celgene Kappa Holdings LLC
| |
Bristol-Myers Squibb International Co. ULC
| |
Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH
| |
Seamair Insurance DAC
|
Insurance Brokers/Services
|
Bristol-Myers Squibb AE
| |
Swords Laboratories Unlimited Co.
![]() Swords Laboratories Unlimited Co. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Swords Laboratories Unlimited Co. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Swords, Ireland. |
Pharmaceuticals: Major
|
BMS Strategic Portfolio Investments Holdings, Inc.
|
Sektor
Umsatz je Region
![Analystenschätzungen](/images/consensus_flch.gif)
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+52,93 % | 803 Mrd. | |
+40,98 % | 629 Mrd. | |
-7,08 % | 351 Mrd. | |
+17,40 % | 324 Mrd. | |
+10,58 % | 303 Mrd. | |
+16,42 % | 244 Mrd. | |
+2,17 % | 226 Mrd. | |
+10,66 % | 215 Mrd. | |
+6,24 % | 164 Mrd. |
- Börse
- Aktien
- 850501 Aktie
- 850501 Aktie
- Unternehmen Bristol-Myers Squibb Company